Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-14

Clinical Trial Update: Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients . [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effect of cholecalciferol (vitamin D3) supplementation on disease activity and quality of life in systemic lupus erythematosus pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Dr Cipto Mangunkusumo General Hospital | Conditions: Lupus Erythematosus, Systemic, Cholecalciferol Supplementation | Phase 3 | Status: COMPLETED